Michael Edmonds Selected Research

sucrose octasulfate

1/2021	Managing Diabetic Foot Ulcers: Pharmacotherapy for Wound Healing.
1/2018	Sucrose octasulfate dressing versus control dressing in patients with neuroischaemic diabetic foot ulcers (Explorer): an international, multicentre, double-blind, randomised, controlled trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Michael Edmonds Research Topics

Disease

18	Diabetic Foot 01/2022 - 01/2006
14	Ulcer 01/2022 - 01/2006
11	Infections 06/2021 - 09/2005
9	Wounds and Injuries (Trauma) 12/2021 - 01/2006
4	Foot Ulcer 10/2021 - 01/2006
2	Type 2 Diabetes Mellitus (MODY) 02/2022 - 03/2009
2	Peripheral Arterial Disease 04/2017 - 05/2015
2	Pain (Aches) 05/2015 - 01/2014
2	Necrosis 06/2008 - 01/2006
1	Suppuration 02/2022
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 02/2022
1	Convalescence 12/2020
1	Thrombophilia 12/2020
1	COVID-19 12/2020
1	Wound Infection (Wound Infections) 01/2018
1	Fever (Fevers) 05/2015
1	Edema (Dropsy) 05/2015
1	Chronic Limb-Threatening Ischemia 05/2013
1	Cellulitis 01/2009

Drug/Important Bio-Agent (IBA)

5	Anti-Bacterial Agents (Antibiotics)IBA 09/2019 - 09/2005
2	Oxygen (Dioxygen)IBA 01/2021 - 01/2020
2	sucrose octasulfateIBA 01/2021 - 01/2018
2	ApligrafIBA 01/2010 - 03/2009
1	CholesterolIBA 10/2021
1	HydrogelsIBA 01/2021
1	FibrinIBA 01/2021
1	Peptides (Polypeptides)IBA 01/2021
1	Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric 01/2021
1	Hyaluronic Acid (Hyaluronan)IBA 01/2021
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2021
1	fibrin fragment D (D-dimer)IBA 12/2020
1	Antiviral Agents (Antivirals)IBA 12/2020
1	Pharmaceutical PreparationsIBA 12/2020
1	Heparin (Liquaemin)FDA LinkGeneric 12/2020
1	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 12/2020
1	AnticoagulantsIBA 12/2020
1	betrixabanIBA 12/2020
1	RivaroxabanIBA 12/2020
1	salicylhydroxamic acid (SHAM)IBA 01/2020
1	AmberIBA 09/2019
1	C-Reactive ProteinIBA 05/2015
1	PlasticsIBA 09/2014
1	CollagenIBA 05/2012
1	Gentamicins (Gentamicin)FDA LinkGeneric 05/2012
1	Ertapenem (Invanz)FDA Link 01/2009
1	Antidepressive Agents (Antidepressants)IBA 06/2007

Therapy/Procedure

11	Surgical Amputation (Amputations) 02/2022 - 01/2006
10	Therapeutics 01/2021 - 09/2005
7	Debridement 02/2022 - 09/2005
2	Drug Therapy (Chemotherapy) 01/2022 - 01/2021
1	Contraindications 12/2020
1	Length of Stay 09/2019
1	Cell- and Tissue-Based Therapy (Cell Therapy) 01/2010
1	Glycemic Control 03/2009